Bio Medica Laboratories IPO vs Sri Priyanka Geo Commex IPO

Comparison between Bio Medica Laboratories IPO and Sri Priyanka Geo Commex IPO.

IPO Details

Bio Medica Laboratories IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Sri Priyanka Geo Commex IPO is a SME Bookbuilding proposed to list at NSE SME.

Issue Size and Price

The total issue size of Bio Medica Laboratories IPO is up to ₹49.80 Cr whereas the issue size of the Sri Priyanka Geo Commex IPO is up to ₹0.00 Cr. The final issue price of Bio Medica Laboratories IPO is ₹139.00 per share and of Sri Priyanka Geo Commex IPO is .

 Bio Medica Laboratories IPOSri Priyanka Geo Commex IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹132.00 per share
Issue Price (Upper)₹139.00 per share
Issue Price (Final)₹139.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size1000 shares
Fresh Issue Size32,06,000 shares45,00,000 shares
Fresh Issue Size (Amount)up to ₹44.56 Crup to ₹0.00 Cr
OFS Issue Size3,77,000 shares0 shares
OFS Issue Size (Amount)up to ₹5.24 Crup to ₹0.00 Cr
Issue Size Total35,83,000 shares45,00,000 shares
Issue Size Total (Amount)up to ₹49.80 Crup to ₹0.00 Cr

IPO Timetable

Bio Medica Laboratories IPO opens on May 21, 2026, while Sri Priyanka Geo Commex IPO opens on . The closing date of Bio Medica Laboratories IPO and Sri Priyanka Geo Commex IPO is May 25, 2026, and , respectively.

Financials & KPIs

Bio Medica Laboratories IPO P/E ratio is 13.03, as compared to Sri Priyanka Geo Commex IPO P/E ratio of .

 Bio Medica Laboratories IPOSri Priyanka Geo Commex IPO
Financials

Company Financials (Restated)

Period Ended30 Nov 202531 Mar 202531 Mar 202431 Mar 2023
Assets65.1739.1219.5317.57
Total Income28.6338.3315.3416.25
Profit After Tax8.669.792.500.33
EBITDA13.4515.215.631.70
NET Worth17.1214.734.942.44
Reserves and Surplus7.945.554.842.34
Total Borrowing38.1715.0110.499.61
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets81.2267.2766.88
Total Income266.65250.19219.48
Profit After Tax9.822.041.33
EBITDA16.466.054.08
NET Worth31.8021.2419.04
Reserves and Surplus28.8418.2816.08
Total Borrowing35.4333.9125.10
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)96.84100
Promoter Shareholding (Post-Issue)
P/E Ratio13.03
Market Cap₹174.79 Cr.
ROE99.5937.03
ROCE48.2045.94
Debt/Equity1.021.11
EPS₹10.67
RoNW99.5930.88

Shares Offered

In the Bio Medica Laboratories IPO Retail Individual Investors (RII) are offered 17,92,000 shares while in Sri Priyanka Geo Commex IPO retail investors are offered 17,92,000 shares. Qualified Institutional Buyers (QIB) are offered 36,000 shares in Bio Medica Laboratories IPO and 0 shares in Sri Priyanka Geo Commex IPO.

 Bio Medica Laboratories IPOSri Priyanka Geo Commex IPO
Anchor Investor Reservation0 shares
Market Maker Reservation1,89,000 shares0 shares
QIB36,000 shares0 shares
NII17,55,000 shares0 shares
RII17,92,000 shares0 shares
Employee0 shares0 shares
Others
Total35,83,000 shares0 shares

Bids Received (Subscription)

Bio Medica Laboratories IPO subscribed 2.26x in total, whereas Sri Priyanka Geo Commex IPO subscribed .

Compare with others

Compare:

Bio Medica Laboratories IPO Vs Sri Priyanka Geo Commex IPO